Literature DB >> 28716587

Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers.

Stefano Cobianchi1, Jessica Jaramillo2, Siro Luvisetto3, Flaminia Pavone3, Xavier Navarro2.   

Abstract

The injection of safe doses of botulinum neurotoxin A (BoNT/A) have been reported to be useful for the treatment of neuropathic pain, but it is still unknown how functional recovery is induced after peripheral nerve injury. We evaluated the effects of intranerve application of BoNT/A, on regeneration and sensorimotor functional recovery in partial and complete peripheral nerve injuries in the mouse. After sciatic nerve crush (SNC) and intranerve delivery of BoNT/A (15pg), axonal regeneration was measured by nerve pinch test at different days. Regeneration of myelinated and unmyelinated fibers was assessed by immunohistochemical double labeling for NF200/GAP43 and CGRP/GAP43. S100 was used as Schwann cells marker. Medial footpad skin reinnervation was assessed by PGP staining. Motor functions were assessed by means of nerve conduction tests. In other mice groups, nerve conduction tests were performed also after chronic constriction injury (CCI) of the sciatic nerve and intraplantar injection of BoNT/A (15pg). In SNC mice, BoNT/A increased the rate of axonal regeneration. The advantage of regrowing myelinated axons after BoNT/A injection was evidenced by longer NF200+ nerve profiles and confirmed by nerve histology. We observed also a higher expression of S100 in the distal portion of BoNT/A-injected regenerated nerves. In CCI mice, BoNT/A induced an increase in reinnervation of gastrocnemius and plantar muscles. These results show that a low dose of BoNT/A, insufficient to produce muscular dysfunction, conversely speeds up sensorimotor recovery by stimulating myelinated axonal regeneration, and points out its application as a multipotent treatment for peripheral neuropathies.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  axonal regeneration; botulinum toxin; functional recovery; hyperalgesia

Mesh:

Substances:

Year:  2017        PMID: 28716587     DOI: 10.1016/j.neuroscience.2017.07.011

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  [Regulatory role of long non-coding RNA in peripheral nerve injury and neural regeneration].

Authors:  Ying Peng; Haodong Lin
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-08-15

Review 2.  Revisiting the Role of Biologically Active Natural and Synthetic Compounds as an Intervention to Treat Injured Nerves.

Authors:  Natália Melo Souza; Mateus Figueiredo Gonçalves; Luiz Fernando Romanholo Ferreira; Muhammad Bilal; Hafiz M N Iqbal; Renato Nery Soriano
Journal:  Mol Neurobiol       Date:  2021-07-06       Impact factor: 5.590

3.  Long non-coding RNA NONMMUG014387 promotes Schwann cell proliferation after peripheral nerve injury.

Authors:  Bin Pan; Zhong-Ju Shi; Jia-Yin Yan; Jia-He Li; Shi-Qing Feng
Journal:  Neural Regen Res       Date:  2017-12       Impact factor: 5.135

4.  Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model.

Authors:  Alba Finocchiaro; Sara Marinelli; Federica De Angelis; Valentina Vacca; Siro Luvisetto; Flaminia Pavone
Journal:  Toxins (Basel)       Date:  2018-03-18       Impact factor: 4.546

Review 5.  Botulinum Toxin and Neuronal Regeneration after Traumatic Injury of Central and Peripheral Nervous System.

Authors:  Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2020-07-02       Impact factor: 4.546

6.  Berberine promotes nerve regeneration through IGFR‑mediated JNK‑AKT signal pathway.

Authors:  Hai-Na Zhang; Ya-Juan Sun; Huai-Qiang He; Hong-Yan Li; Qiu-Li Xue; Zhong-Min Liu; Guang-Meng Xu; Li-Hua Dong
Journal:  Mol Med Rep       Date:  2018-09-24       Impact factor: 2.952

Review 7.  Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain-Narrative Review.

Authors:  Magdalena Kocot-Kępska; Renata Zajączkowska; Joanna Mika; David J Kopsky; Jerzy Wordliczek; Jan Dobrogowski; Anna Przeklasa-Muszyńska
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

8.  Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice.

Authors:  Wei-Jia Chen; Jing-Qi Niu; Yi-Ting Chen; Wen-Jing Deng; Ying-Ying Xu; Jing Liu; Wei-Feng Luo; Tong Liu
Journal:  J Headache Pain       Date:  2021-05-17       Impact factor: 7.277

9.  Botulinum Neurotoxin Application to the Severed Femoral Nerve Modulates Spinal Synaptic Responses to Axotomy and Enhances Motor Recovery in Rats.

Authors:  Marcel Irintchev; Orlando Guntinas-Lichius; Andrey Irintchev
Journal:  Neural Plast       Date:  2018-09-05       Impact factor: 3.599

10.  Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice.

Authors:  Valentina Vacca; Luca Madaro; Federica De Angelis; Daisy Proietti; Stefano Cobianchi; Tiziana Orsini; Pier Lorenzo Puri; Siro Luvisetto; Flaminia Pavone; Sara Marinelli
Journal:  Toxins (Basel)       Date:  2020-07-31       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.